GONUTS has been updated to MW1.31 Most things seem to be working but be sure to report problems.
TableEdit
PMID:21857966
You don't have sufficient rights on this wiki to edit tables. Perhaps you need to log in. Changes you make in the Table editor will not be saved back to the wiki
See Help for Help on this wiki. See the documentation for how to use the table editor
Citation |
Li, B, Zhong, L, Yang, X, Andersson, T, Huang, M and Tang, SJ (2011) WNT5A signaling contributes to Aβ-induced neuroinflammation and neurotoxicity. PLoS ONE 6:e22920 |
---|---|
Abstract |
Neurodegenration is a pathological hallmark of Alzheimer's disease (AD), but the underlying molecular mechanism remains elusive. Here, we present evidence that reveals a crucial role of Wnt5a signaling in this process. We showed that Wnt5a and its receptor Frizzled-5 (Fz5) were up-regulated in the AD mouse brain, and that beta-amyloid peptide (Aβ), a major constituent of amyloid plaques, stimulated Wnt5a and Fz5 expression in primary cortical cultures; these observations indicate that Wnt5a signaling could be aberrantly activated during AD pathogenesis. In support of such a possibility, we observed that inhibition of Wnt5a signaling attenuated while activation of Wnt5a signaling enhanced Aβ-evoked neurotoxicity, suggesting a role of Wnt5a signaling in AD-related neurodegeneration. Furthermore, we also demonstrated that Aβ-induced neurotoxicity depends on inflammatory processes, and that activation of Wnt5a signaling elicited the expression of proinflammatory cytokines IL-1β and TNF-α whereas inhibition of Wnt5a signaling attenuated the Aβ-induced expression of the cytokines in cortical cultures. Our findings collectively suggest that aberrantly up-regulated Wnt5a signaling is a crucial pathological step that contributes to AD-related neurodegeneration by regulating neuroinflammation. |
Links |
PubMed PMC3157339 Online version:10.1371/journal.pone.0022920 |
Keywords |
Alzheimer Disease/genetics; Alzheimer Disease/metabolism; Amyloid beta-Peptides/genetics; Amyloid beta-Peptides/metabolism; Amyloid beta-Peptides/pharmacology; Amyloid beta-Protein Precursor/genetics; Amyloid beta-Protein Precursor/metabolism; Animals; Blotting, Western; Cell Survival/drug effects; Cells, Cultured; Hippocampus/metabolism; Hippocampus/pathology; Humans; Hydrogen Peroxide/pharmacology; Immunohistochemistry; Interleukin-1beta/metabolism; Mice; Mice, Inbred C57BL; Mice, Transgenic; Neurons/drug effects; Neurons/metabolism; Neurotoxicity Syndromes/genetics; Neurotoxicity Syndromes/metabolism; Oxidants/pharmacology; Peptide Fragments/genetics; Peptide Fragments/metabolism; Peptide Fragments/pharmacology; Recombinant Proteins/metabolism; Recombinant Proteins/pharmacology; Signal Transduction/drug effects; Tumor Necrosis Factor-alpha/metabolism; Wnt Proteins/genetics; Wnt Proteins/metabolism; Wnt Proteins/pharmacology; Wnt-5a Protein |
public |
Cancel |